Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors. [electronic resource]
Producer: 20190128Description: 409-418 p. digitalISSN:- 1178-2048
- Administrative Claims, Healthcare
- Adolescent
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Anticholesteremic Agents -- administration & dosage
- Atherosclerosis -- blood
- Biomarkers -- blood
- Cholesterol, LDL -- blood
- Databases, Factual
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Formularies as Topic
- Humans
- Hyperlipoproteinemia Type II -- blood
- Male
- Medicare -- trends
- Middle Aged
- PCSK9 Inhibitors
- Practice Patterns, Physicians' -- trends
- Proprotein Convertase 9 -- metabolism
- Retrospective Studies
- Serine Proteinase Inhibitors -- administration & dosage
- Time Factors
- Treatment Outcome
- United States
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.